Upgrade to SI Premium - Free Trial

Evoke Pharma (EVOK) Reports In-Line Q1 EPS

May 14, 2015 4:24 PM

Evoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.55), in-line with the analyst estimate of ($0.55).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

Categories

Earnings

Next Articles